Calendar

Latest Presentations

Oppenheimer 25th Healthcare Conference

10th December 2014
View the company overview presentation on the DMD and CDI programmes


WMS 2014 Presentations

8th October 2014
Data on utrophin modulation programme for DMD presented at WMS

Stocks

Share Price

LSE (SUMM)
118.00 +0.50
at closed 28 Jan 2015

15 minute delayed share price from London Stock Exchange provided by Hemscott Group Limited

Current Programmes

  • C. Difficile Infections banner image

    C. Difficile Infections

    Clostridium difficile infection (‘CDI’) is a major healthcare issue in hospitals and long-term care homes, and increasingly in the wider community. It is a serious illness caused by infection of the colon by the bacteria, C. difficile, which produces toxins that cause inflammation, severe diarrhoea and can in the most serious of cases be fatal.

    Read More
  • Duchenne Muscular Dystrophy image boy

    Duchenne Muscular Dystrophy

    Duchenne Muscular Dystrophy (‘DMD’) is a fatal, genetic disease that predominantly affects boys. It has a population of around 50,000 in the developed world and is classified as a rare or orphan disease. DMD is caused by the absence of a protein called dystrophin which is essential in maintaining the healthy function of muscles in the body.

    Currently there is no cure.

    Read More